Mercredi septembre 22, 2021 11h - 12h30 EDT en ligne
A live panel discussion about the value and perils of paid participation in stem cell research and clinical trials.
Typically, patients do not have to pay to participate in clinical trials; however, as research funding continues to shrink, the growth of pay-to-participate trials has increased. In this webinar, a panel of experts will discuss the benefits of this research funding model as well the potentials for misuse and ethical concerns.
Moderator : Anthony Atala, MD - Director, Wake Forest Institute for Regenerative Medicine
Arthur L. Caplan, PhD - NYU Grossman School of Medicine